1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Tibolone
Trade Name:
Tibella
Manufacturer/Distributor:
BioSyent Pharma Inc.
Classification:
Hormone replacement therapy
ATC Class:
G03CX01 - tibolone
Status:
active
Notice of Compliance (yyyy/mm/dd):
2019/05/09
Date Marketed in Canada (yyyy/mm/dd):
2020/07/29
Presentation:
Tablet: 2.5 mg. DIN: 02488361
Comments:
For short-term treatment of vasomotor symptoms due to estrogen deficiency in postmenopausal women, more than one year after menopause.
Source:
Product monograph
Back to:
Drug Product Listings 
